Trade secrets trial delayed
The corporate trade secrets theft trial of former Bridgestone Americas researcher and Hudson resident Xiaorong Wang is now scheduled for 8 a.m. Sept. 17 in U.S. District Court in Cleveland. A jury trial originally was scheduled for this week.
Both Wang and the U.S. government agreed they need more time to go through thousands of documents, about 28,000 emails — some of which need to be translated from Chinese — plus computers, according to court documents.
U.S. District Court Judge James Gwin declared the case “complex” and found that the “ends of justice served” by granting the continuance “outweigh the best interest of the public and the defendant in a speedy trial.”
Wang is a naturalized U.S. citizen born in China and was one of Bridgestone Americas’ top researchers in Akron. He has pleaded not guilty to charges he stole trade secrets from the tire maker’s Akron research center and lied to federal investigators. He was indicted and arrested in March.
Warfarin competitor rejected
In a move that came as a surprise to researchers and analysts, the Food and Drug Administration has decided not to approve — for now — the anti-clotting drug Eliquis, viewed as the next blockbuster for its makers, Bristol-Myers Squibb and Pfizer.
The companies said the agency had asked them for more information about managing and verifying data from a large study that compared Eliquis with warfarin, the current treatment standard for millions of people with a heart rhythm problem called atrial fibrillation. The request was the second major delay for the drug; in February, the FDA asked for more time to consider the application.
In a news release announcing the decision, Bristol-Myers and Pfizer said the agency had not asked for any new studies.
“We don’t believe that the information impacts the benefit-risk profile of the drug,” said Laura Hortas, a Bristol-Myers spokeswoman. She noted that the trial was complex, involving more than 18,000 people worldwide. The news, she said, “is disappointing, but it does not alter our confidence in the therapeutic profile of Eliquis.”
The decision surprised cardiologists and financial analysts, two communities that have closely followed the drug’s development. Eliquis, which is also known by the scientific name apixaban, is considered by some to be the best of a new class of drugs aimed at replacing warfarin, which is inexpensive but requires careful monitoring to avoid dangerous side effects.
Bond information available
The state budget office has recently opened a new online site for those interested in Ohio’s bond activity and debt portfolio.
The Bonds and Investor Relations Portal can be accessed through the Office of Budget and Management at http://obm.ohio.gov, then clicking on “Bonds and Investors” at the top of the site.
The site provides access to state budget, finances, debt and economic data. It also includes historical financial reports, state credit ratings and a calendar for all state-level bond issuers.
“Fast Internet access to the most current information is increasingly important to individuals, funds, businesses and organizations that invest in state of Ohio bonds and notes,” said state Budget Director Timothy S. Keen.
Facebook change unpopular
Facebook has changed your email address. At least that’s how many felt after a quiet but vast change in the way the company displays users’ contact information.
Facebook replaced the email address users chose when they signed up and changed it to a facebook.com address. The Facebook email accounts allow users to communicate with outside email addresses via Facebook.
The changes were first pointed out by bloggers over the weekend and publicized by media outlets Monday, leading to gripes from users, usually on their Facebook pages.
The company said in a statement in April that it was “updating addresses on Facebook to make them consistent across our site.”
Facebook spokeswoman Jillian Stefanki said the site is also rolling out a setting that allows people to decide which email addresses to show on their pages.
“Ever since the launch of timeline, people have had the ability to control what posts they want to show or hide on their own timelines,” Stefanki said in an email late Monday.
Oxygen rules are changed
Federal aviation officials will order airlines to put oxygen systems back in jet restrooms, reversing a decision last year to remove them because of fears that terrorists could use them to start a fire during flight.
Compiled from staff and wire reports